Calsyntenin-2 promotes the pathology of acute myeloid leukemia via activation of the JAK2-STAT3 signaling pathway.
PURPOSE Although considerable progress has been made in the treatment of acute myeloid leukemia (AML), therapeutic outcomes remain unsatisfactory. Thus, it is of great important to investigate the leukemiagenesis mechanism of AML. Previous studies indicated that Calsyntenin-2 (CLSTN2) was closely associated with the pr...